People · Operator
Named in public records as an officer, director or promoter · active 2018–2018 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Avant Diagnostics, Inc | — | Biotechnology | Seed | $1.3M | $51.7M | 2018 |
John Brugmann at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Brugmann on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Randall Letcavage | 1 | 2 |
| Jeff Stephens | 1 | 2 |
| Joseph Roth | 1 | 1 |
| Michael Ruxin, M.D. | 1 | 1 |
| Scott VanderMeer | 1 | 1 |
| Jeff Busch | 1 | 1 |
| Robert Trapp | 1 | 1 |
| Gregg Linn | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.